Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Seasonal variation in the toxicological properties of size-segregated indoor and outdoor air particulate matter.

Happo M, Markkanen A, Markkanen P, Jalava P, Kuuspalo K, Leskinen A, Sippula O, Lehtinen K, Jokiniemi J, Hirvonen MR.

Toxicol In Vitro. 2013 Aug;27(5):1550-61. doi: 10.1016/j.tiv.2013.04.001. Epub 2013 Apr 11.

PMID:
23583641
2.

Toxicological properties of emission particles from heavy duty engines powered by conventional and bio-based diesel fuels and compressed natural gas.

Jalava PI, Aakko-Saksa P, Murtonen T, Happo MS, Markkanen A, Yli-Pirilä P, Hakulinen P, Hillamo R, Mäki-Paakkanen J, Salonen RO, Jokiniemi J, Hirvonen MR.

Part Fibre Toxicol. 2012 Sep 29;9:37. doi: 10.1186/1743-8977-9-37.

3.

Toxicological effects of emission particles from fossil- and biodiesel-fueled diesel engine with and without DOC/POC catalytic converter.

Jalava PI, Tapanainen M, Kuuspalo K, Markkanen A, Hakulinen P, Happo MS, Pennanen AS, Ihalainen M, Yli-Pirilä P, Makkonen U, Teinilä K, Mäki-Paakkanen J, Salonen RO, Jokiniemi J, Hirvonen MR.

Inhal Toxicol. 2010 Dec;22 Suppl 2:48-58. doi: 10.3109/08958378.2010.519009. Epub 2010 Oct 29.

PMID:
21029031
4.
5.

Quantifying the indicator power of an indicator species.

Halme P, Mönkkönen M, Kotiaho JS, Ylisirniö AL, Markkanen A.

Conserv Biol. 2009 Aug;23(4):1008-16. doi: 10.1111/j.1523-1739.2009.01206.x.

PMID:
19627324
6.

Pre-exposure to 50 Hz magnetic fields modifies menadione-induced DNA damage response in murine L929 cells.

Markkanen A, Juutilainen J, Naarala J.

Int J Radiat Biol. 2008 Sep;84(9):742-51. doi: 10.1080/09553000802360836.

PMID:
18821388
7.

Indoor transformer stations as predictors of residential ELF magnetic field exposure.

Ilonen K, Markkanen A, Mezei G, Juutilainen J.

Bioelectromagnetics. 2008 Apr;29(3):213-8.

PMID:
18044741
8.

Cellular effects of electromagnetic fields.

Naarala J, Höytö A, Markkanen A.

Altern Lab Anim. 2004 Oct;32(4):355-60. Review.

PMID:
15651919
9.

The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.

Kubaszek A, Markkanen A, Eriksson JG, Forsen T, Osmond C, Barker DJ, Laakso M.

J Clin Endocrinol Metab. 2004 May;89(5):2044-7.

PMID:
15126519
10.

Apoptosis induced by ultraviolet radiation is enhanced by amplitude modulated radiofrequency radiation in mutant yeast cells.

Markkanen A, Penttinen P, Naarala J, Pelkonen J, Sihvonen AP, Juutilainen J.

Bioelectromagnetics. 2004 Feb;25(2):127-33.

PMID:
14735563
11.

Effects of 50 Hz magnetic field on cell cycle kinetics and the colony forming ability of budding yeast exposed to ultraviolet radiation.

Markkanen A, Juutilainen J, Lang S, Pelkonen J, Rytömaa T, Naarala J.

Bioelectromagnetics. 2001 Jul;22(5):345-50.

PMID:
11424158
12.

Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.

Rissanen J, Markkanen A, Kärkkäinen P, Pihlajamäki J, Kekäläinen P, Mykkänen L, Kuusisto J, Karhapää P, Niskanen L, Laakso M.

Diabetes Care. 2000 Jan;23(1):70-3.

13.

High incidence of Alloiococcus otitis in otitis media with effusion.

Hendolin PH, Kärkkäinen U, Himi T, Markkanen A, Ylikoski J.

Pediatr Infect Dis J. 1999 Oct;18(10):860-5.

PMID:
10530580
14.

Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions.

Hendolin PH, Markkanen A, Ylikoski J, Wahlfors JJ.

J Clin Microbiol. 1997 Nov;35(11):2854-8.

15.

[Rhabdomyosarcoma in the middle ear of a three year old male].

Markkanen A, Vornanen M, Riikonen P.

Duodecim. 1996;112(11):1005-7. Finnish. No abstract available.

PMID:
10592996
16.

Constitutional translocation t(3;6)(p14;p11) in a family with hematologic malignancies.

Markkanen A, Ruutu T, Rasi V, Franssila K, Knuutila S, de la Chapelle A.

Cancer Genet Cytogenet. 1987 Mar;25(1):87-95.

PMID:
3467836
17.

Distal trisomy 14q syndrome; a case report.

Markkanen A, Somer M, Nordström AM.

Clin Genet. 1984 Sep;26(3):231-4. No abstract available.

PMID:
6478645
18.

[A familial cancer syndrome].

Mecklin JP, Järvinen HJ, Elomaa I, Karjalainen K, Kemppainen K, Silvola H, Markkanen A.

Duodecim. 1984;100(18):1152-7. Finnish. No abstract available.

PMID:
6510275
19.

A new heritable fragile site on human chromosome 3.

Markkanen A, Knuutila S, de la Chapelle A.

Hereditas. 1983;99(2):317. No abstract available.

20.

Inducible fragile site on chromosome 3.

Markkanen A, Knuutila S, de la Chapelle A.

Hum Genet. 1983;65(2):217-8. No abstract available.

PMID:
6654339
21.

Methotrexate-induced increase in gap formation in human chromosome band 3p14.

Markkanen A, Heinonen K, Knuutila S, de la Chapelle A.

Hereditas. 1982;96(2):317-9. No abstract available.

22.

Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.

Krusius FE, Markkanen A, Peltola P.

Ann Rheum Dis. 1970 May;29(3):232-5. No abstract available.

23.

PERICARDIAL MESOTHELIOMA.

VIRKKUNEN M, TURUNEN M, MARKKANEN A.

Ann Med Intern Fenn. 1963;52:231-6. No abstract available.

PMID:
14080535
24.

Carbutamide in diabetes: report of a long-term trial, with special reference to late failures.

MARKKANEN A, OKA M, PELTOLA P.

Br Med J. 1960 Apr 9;1(5179):1089-91. No abstract available.

25.

On the emotional eosinopenic reaction caused by examination.

MARKKANEN A, PEKKARINEN A, PULKKINEN K, SIMOLA PE.

Acta Physiol Scand. 1956 Feb 20;35(3-4):225-39. No abstract available.

PMID:
13313181

Supplemental Content

Loading ...
Support Center